Connection

Stephen Kent to Pandemics

This is a "connection" page, showing publications Stephen Kent has written about Pandemics.
Connection Strength

0.021
  1. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021 06; 21(6):395-404.
    View in: PubMed
    Score: 0.008
  2. 2017 international meeting of the Global Virus Network. Antiviral Res. 2018 05; 153:60-69.
    View in: PubMed
    Score: 0.006
  3. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
    View in: PubMed
    Score: 0.002
  4. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
    View in: PubMed
    Score: 0.002
  5. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
    View in: PubMed
    Score: 0.002
  6. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.